Description
Suiferrin 100 mg/ml solution for injection for cattle and pigs
Statement of the active substance(s) and other ingredient(s)
Each ml contains:
Active substance:
Iron (III) hydroxide dextran complex 100 mg
Excipients:
Phenol 5 mg
Dark brown solution.
Target species
Cattle (calves), pigs (piglets, weaners).
Indications for use
Prevention and treatment of iron-deficiency anaemia. This veterinary medicinal product corrects iron deficiency in the body, it stimulates the haematopoietic system to produce haemoglobin, it raises red blood cell levels.
Contraindications
Do not use in case of hepatic impairment and renal failure.
Do not use in case of known sensitivity to the active substance or any of the excipients.
Do not use in case of anaemia other than iron-deficiency anaemia.
Special warnings
Special precautions for safe use in the target species:
Iron dextran in weaners can induce anaphylaxis. The causes may include genetic factors, and vitamin E and/or selenium deficiency.
In case of suspected vitamin E and/or selenium deficiency, do not administer products containing iron compounds.
Do not give the product by routes of administration other than recommended. Intravenous use may lead to acute poisoning manifested primarily in anaphylaxis. Possible effects may include sudden death without prodromal symptoms or symptoms of the nervous system, such as balance disorders, progressive depression leading to a coma. After per os administration, animals can experience vomiting blood, diarrhoea or constipation.
Special precautions to be taken by the person administering the veterinary medicinal product to animals:
Keep caution to avoid accidental self-injection. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Interaction with other medicinal products and other forms of interaction:
The product should not be administered with oral products containing iron.
It is not recommended to use the product with tetracyclines and chelating agents as iron ions may form sparingly soluble complexes preventing absorption.
Overdose:
Overdosing the product may cause gastrointestinal tract disorders: vomiting blood, diarrhoea or constipation. Elevated iron levels can cause shock, cardiac disorders leading to collapse, dyspnoea and renal failure manifested by oliguria or anuria.
Signs of chronic iron overload result from liver disorders caused by accumulation of iron in hepatocytes and Kupffer cells.
Major incompatibilities:
In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Adverse events
Target species: cattle, pig.
| Rare (1 to 10 animals/10 000 animals treated): | Anaphylaxis1 |
| Frequency unknown (cannot be determined based on the available data): | Death2 Reaction at the injection site3 Hypersensitive reaction4 |
1 Occurs in weaners. The causes may include genetic factors, vitamin E or selenium deficiency.
2 The causes may include genetic factors, vitamin E or selenium deficiency.
3 Irritation, oedema and brown pigmentation of adjacent tissues may occur at the injection site.
4 May occur in piglets in case of significant vitamin E and/or selenium deficiency in sow’s diet. Hypersensitivity is manifested by nausea, vomiting and sudden death within about one hour after administration of products containing iron.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. If you notice any side effects, even those not already listed in this package leaflet, or you think that the medicine has not worked, please contact, in the first instance, your veterinarian. You can also report any adverse events to the marketing authorization holder using the contact details found at the end of this leaflet, or via your national reporting system:
Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,
Al. Jerozolimskie 181C, PL-02-222 Warsaw, Tel.: +48 22 49 21 687, Fax: +48 22 49 21 605
E-mail: pw@urpl.gov.pl
Website: https://smz.ezdrowie.gov.pl
Dosage for each target species, route(s) and method(s) of administration
Intramuscular or subcutaneous use.
Piglets, weaners: 2 ml/animal
Calves: 4-8 ml/animal.
Advice on correct administration
None.
Withdrawal period(s)
Meat and offal: zero days
Special precautions for storage
Keep out of the sight and reach of children.
Do not store above 25°C.
Store in the original package to protect from light.
Do not freeze.
Do not use this veterinary medicinal product after the expiry date which is stated on the label after “Exp”. The expiry date refers to the last day of that month.
Shelf-life after first opening the immediate packaging: 28 days.
Special precautions for disposal
Medicines should not be disposed of via wastewater or household waste.
Use take-back schemes for the disposal of any unused veterinary medicinal product or waste materials derived thereof in accordance with local requirements and with any applicable national collection systems. These measures should help to protect the environment.
Ask your veterinary surgeon how to dispose of medicines no longer required.
Classification of veterinary medicinal products
Veterinary medicinal product subject to a veterinary prescription.
Marketing authorisation numbers and pack sizes
2087/11
Pack sizes: 100 ml and 250 ml
Date on which the package leaflet was last revised
17/06/2025
Detailed information on this veterinary medicinal product is available in the Union Product Database (https://medicines.health.europa.eu/veterinary).
Contact details
Marketing authorisation holder and manufacturer responsible for batch release:
Biowet Puławy Sp. z o.o.
Henryka Arciucha 2
24-100 Puławy
Poland
Tel./Fax: + 48 (81) 886 33 53, Tel: + 48 (81) 888 91 00
e-mail: sekretariat@biowet.pl
Contact details to report suspected adverse events:
Biowet Puławy Sp. z o.o.
Henryka Arciucha 2
24-100 Puławy
Poland
Tel.: + 48 (81) 888 91 33, Tel: +48 509 750 444
e-mail: biowet@biowet.pl
SPC: 2025-06-17
2025-07-17
